Diamonds and Dogs


BioNTech (BNTX) up 6% as their COVID-19 vaccine moves forward. BioNTech along with partner Pfizer are getting a "rolling submission" for approval of their Covid-19 vaccine candidate from the European Medicines Agency. Pfizer has said initial Phase 3 clinical trial results could be in by the end of October. Analysts have widely given the lead to BioNTech and Pfizer for getting their vaccine to market first. Four other companies or teams are also in final-phase testing of a Covid-19 vaccine.

Boeing (BA) lowers 20-year forecast for airplane demand. Boeing is down 3% after rising 3% to start the day after they lowered their 20-year demand forecast with most of the decline coming this decade. Boeing predicts airplane deliveries to be cut to 18,350 for 2020-2029, down 10.7% from an unpublished forecast of 20,550 embedded in the last report. Demand would return towards previous trends in the 2030s. This is the first time since the 2009 financial crisis that Boeing cut the 20-year demand forecast in terms of the number of deliveries. Maybe this is a sign of a bottom? 

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.